Propiedades inmunomoduladoras de Withania somnifera: regulación de las células inmunitarias innatas e implicaciones clínicas

allergic and chronic inflammatory disorders. However, critical gaps persist in elucidating its molecular mechanisms, establishing phytochemical standardization, and defining context-specific dosing regimens. Collectively, current evidence positions WS as a promising candidate for the management of autoimmune, infectious, and inflammatory diseases. However, it further highlights the need for rigorous mechanistic studies and well-designed clinical trials to enable its integration into evidence-based therapeutics. © 2026 The Author(s). Phytotherapy Research published by John Wiley & Sons Ltd.